Global launch of new Biosen C-Line glucose and Lactate analyzer

Space-based research uncovers key to cancer cell survival

In October, we think pink, and for a good reason-;one out of every eight women will be diagnosed with breast cancer in their lifetime, and

October 29, 2024

European regulators reaffirm Apellis’ rejection, add eight positive recommendations

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 21, 2024

UCB departs industry trade group BIO, following Pfizer’s exit late last year

Brussels-based biopharma company UCB confirmed Thursday that it decided not to renew its membership in the industry group BIO in 2024, the second high-profile exit

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.